Alnylam Pharmaceuticals
ALNY
#575
Rank
$34.99 B
Marketcap
$271.31
Share price
-2.11%
Change (1 day)
55.11%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company